Home>Topics>Companies>St. Jude Medical

St. Jude Medical STJ

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. Headlines
    1. Medtronic Wraps up Fiscal 2012 With Solid 4Q

      Commentary

      Tue, 22 May 2012

      saw slight declines in its share of de novo CRT-D implants, as practitioners have begun switching over to St . Jude Medical 's STJ new Unify Quadra implant. While management contends that this share decline is likely temporary, based on usage

    2. Why We Think St . Jude Is Undervalued

      Headlines

      Thu, 17 May 2012

      process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In St . Jude 's ( STJ ) case, we think the firm is undervalued. We think it is fairly valued at $52 per share. For some background, we think

    3. An Exciting New Technology That Could Take Pressure Off St . Jude Medical

      Headlines

      Wed, 16 May 2012

      This is something I had never heard about until St . Jude Medical ( STJ ) mentioned it at their February analyst day after ..... clarify the significance of this new technology for St . Jude Medical 's growth program, we estimate that as many as

    4. St . Jude Medical ([[ STJ ]] +2.1%) ticks higher after being upgraded to Buy at Goldman. The firm cites share gains in its core markets and entrance into new therapeutic categories, which could ...

      Headlines

      Mon, 14 May 2012

      St . Jude Medical ( STJ +2.1% ) ticks higher after being upgraded to Buy at Goldman. The firm cites share gains in its core markets and entrance into

    5. Update: Bullish Case For Boston Scientific

      Headlines

      Thu, 10 May 2012

      of home monitoring capabilities. Home monitoring has given St Jude ( STJ ) and Medtronic ( MDT ) a way to differentiate their product ..... bullish case for BSX and provide for competitive advantages over STJ and MDT products. Note: Medical devices are extremely complicated

    6. St . Jude's Riata lead performed poorly in study

      Headlines

      Thu, 10 May 2012

      May 10 (Reuters) - St . Jude Medical Inc's Riata defibrillator lead, which was recalled late last year, performed "significantly worse" than a competing lead called Quattro, sold by competitor Medtronic Inc, in a large study, researchers said.

    7. New J&J (JNJ) CEO Alex Gorsky is looking to strengthen the company's medical-device unit via takeovers, he tells Bloomberg in an interview. "We remain committed to cardiovascular," Gorsky says, ...

      Headlines

      Tue, 1 May 2012

      takeovers, he tells Bloomberg in an interview. "We remain committed to cardiovascular," Gorsky says, despite sales shrinking 44% since 2006. On the analyst wish list are Edwards Lifesciences ( EW ) and St . Jude Medical ( STJ ). 1 comment!

    8. St Jude Riata heart device problems persist - study

      Headlines

      Tue, 1 May 2012

      CHICAGO, May 1 (Reuters) - St Jude Medical Inc published a report on its website on Tuesday that shows problems with wires that carry electricity from implantable defibrillators to the heart have persisted in the last 3 months.

    9. Bullish Case For Boston Scientific Corp

      Headlines

      Mon, 30 Apr 2012

      BSX ) market capitalization $9 billion. Industry related companies Medtronic ( MDT ) market capitalization of $39 billion St Jude ( STJ ) market capitalization of $12 billion In my prior analysis of Westport Innovations ( WPRT ) on Seeking Alpha ( article can

    10. Sapien Drives Revenue and Earnings Growth for Edward Lifesciences in 1Q

      Commentary

      Wed, 25 Apr 2012

      revenue growth to 67% year over year. For surgical heart valves, Edwards saw a 3% decline following the introduction of St . Jude 's STJ Trifecta tissue valve last year. Nonetheless, Edwards benefited from the product mix that shifted toward higher-margin

    « Prev12345Next »
    Content Partners